David Risinger
Stock Analyst at Leerink Partners
Total Price Targets
21
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 5, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by David Risinger
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | $355.00 | $328.69 | +8.0% | 1 | Mar 5, 2026 |
| BMY | Bristol-Myers Squibb Company | $60.00 | $58.22 | +3.1% | 2 | Jan 13, 2026 |
| LLY | Eli Lilly and Company | $1234.00 | $961.67 | +28.3% | 2 | Jan 5, 2026 |
| ROIV | Roivant Sciences Ltd. | $32.00 | $28.06 | +14.0% | 3 | Dec 15, 2025 |
| XOMA | XOMA Royalty Corp. | $45.00 | $41.23 | +9.1% | 1 | Dec 11, 2025 |
| PCVX | Vaxcyte, Inc. | $77.00 | $57.52 | +33.9% | 3 | Nov 19, 2025 |
| GILD | Gilead Sciences, Inc. | $114.00 | $132.04 | -13.7% | 2 | Jul 14, 2025 |
| TBPH | Theravance Biopharma, Inc. | $10.00 | $16.76 | -40.3% | 1 | Nov 13, 2024 |
| ANAB | AnaptysBio, Inc. | $45.00 | $66.67 | -32.5% | 3 | Nov 6, 2024 |
| REGN | Regeneron Pharmaceuticals, Inc. | $1077.00 | $703.72 | +53.0% | 1 | Sep 24, 2024 |
| ABBV | AbbVie Inc. | $140.00 | $206.29 | -32.1% | 1 | May 24, 2022 |
| PFE | Pfizer Inc. | $55.00 | $26.38 | +108.5% | 1 | May 23, 2022 |
Recent Activity
- Mar 5, 2026— Set$355.00price target onAMGN(Amgen Inc.)
- Jan 13, 2026— Set$60.00price target onBMY(Bristol-Myers Squibb Company)
- Jan 5, 2026— Set$1234.00price target onLLY(Eli Lilly and Company)
- Dec 15, 2025— Set$32.00price target onROIV(Roivant Sciences Ltd.)
- Dec 11, 2025— Set$45.00price target onXOMA(XOMA Royalty Corp.)
- Nov 19, 2025— Set$77.00price target onPCVX(Vaxcyte, Inc.)
- Nov 11, 2025— Set$29.00price target onROIV(Roivant Sciences Ltd.)
- Jul 14, 2025— Set$114.00price target onGILD(Gilead Sciences, Inc.)
- Nov 13, 2024— Set$10.00price target onTBPH(Theravance Biopharma, Inc.)
- Nov 6, 2024— Set$135.00price target onPCVX(Vaxcyte, Inc.)
- Nov 6, 2024— Set$45.00price target onANAB(AnaptysBio, Inc.)
- Oct 21, 2024— Set$17.00price target onROIV(Roivant Sciences Ltd.)
- Oct 3, 2024— Set$35.00price target onANAB(AnaptysBio, Inc.)
- Sep 24, 2024— Set$1077.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Sep 3, 2024— Set$153.00price target onPCVX(Vaxcyte, Inc.)
- Apr 16, 2024— Set$47.00price target onANAB(AnaptysBio, Inc.)
- Oct 12, 2023— Set$66.00price target onBMY(Bristol-Myers Squibb Company)
- May 24, 2022— Set$140.00price target onABBV(AbbVie Inc.)
- May 23, 2022— Set$55.00price target onPFE(Pfizer Inc.)
- May 23, 2022— Set$341.00price target onLLY(Eli Lilly and Company)
Frequently Asked Questions
Who is David Risinger?
David Risinger is a stock analyst at Leerink Partners covering 12 stocks primarily in Healthcare. They have issued 21 price targets since May 23, 2022.
What stocks does David Risinger cover?
David Risinger currently covers 12 stocks, including ROIV, PCVX, ANAB, BMY, LLY.
What is David Risinger's latest price target?
David Risinger's most recent price target was $355.00 on AMGN (Amgen Inc.), set on Mar 5, 2026.
What is David Risinger's highest price target?
David Risinger's highest issued price target is $1234.00 on LLY, set on Jan 5, 2026.
More Analysts at Leerink Partners
Coverage based on publicly published price targets. Not investment advice.